Titan Medical (NASDAQ:TMDI)‘s stock had its “buy” rating reissued by equities researchers at Piper Jaffray Companies in a note issued to investors on Monday, Stock Target Advisor reports. They presently have a $2.50 price target on the stock. Piper Jaffray Companies’ target price indicates a potential upside of 309.84% from the company’s previous close.
Several other research analysts have also recently weighed in on TMDI. Maxim Group cut Titan Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, October 16th. ValuEngine raised Titan Medical from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Finally, Zacks Investment Research cut Titan Medical from a “buy” rating to a “hold” rating in a research note on Saturday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $4.38.
Shares of TMDI stock opened at $0.61 on Monday. The stock has a 50-day simple moving average of $0.68 and a 200 day simple moving average of $1.87. Titan Medical has a fifty-two week low of $0.38 and a fifty-two week high of $4.65. The stock has a market capitalization of $14.96 million, a P/E ratio of -0.45 and a beta of 4.61.
About Titan Medical
Titan Medical Inc, a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the SPORT Surgical System, a single-port robotic surgical system that comprises a surgeon-controlled patient cart, which includes a 3D vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures.
Featured Story: Real Estate Investment Trust (REIT) ETF
Receive News & Ratings for Titan Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical and related companies with MarketBeat.com's FREE daily email newsletter.